Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» clinical trials
clinical trials
Months after exiting clinical hold, Pfizer readies to resume dosing in phase 3 gene therapy trial
Fierce Biotech
Fri, 09/23/22 - 10:50 am
Pfizer
clinical trials
hemophilia A
gene therapy
FDA
giroctocogene fitelparvovec
Vir doses first subject in Phase II hepatitis D virus treatment trial
Clinical Trials Arena
Fri, 09/23/22 - 10:32 am
Vir Biotechnology
hepatitis D
VIR-2218
VIR-3434
clinical trials
FDA slaps hold on DBV peanut allergy trial in call for protocol changes
Fierce Biotech
Thu, 09/22/22 - 10:33 am
DBV Technologies
clinical trials
FDA
peanut allergy
Novo's Once-Weekly Insulin Treatment Part of a Transforming T2D Space
BioSpace
Thu, 09/22/22 - 10:14 am
Novo Nordisk
clinical trials
type 2 diabetes
diabetes
insulin icodec
United Therapeutics Stops Late-Stage Tyvaso Study In Lung Disease
Yahoo/Benzinga
Wed, 09/21/22 - 10:22 am
United Therapeutics
Tyvaso
COPD
clinical trials
Puma pounces on failed Takeda drug, snapping up cancer prospect for knockdown price
Fierce Biotech
Wed, 09/21/22 - 10:17 am
Puma Biotechnology
Takeda
Aurora A/angiogenic kinase inhibitor
clinical trials
Alisertib
Long after first nod for inhaled Tyvaso, United Therapeutics scraps PhIII in PH with COPD
Endpoints
Tue, 09/20/22 - 10:32 am
Tyvaso
United Therapeutics
PAH
clinical trials
Merck finally gets FDA nod to relaunch HIV trials, but drops preventive therapy plans
Fierce Biotech
Tue, 09/20/22 - 10:26 am
Merck
FDA
clinical trials
islatravir
Clover touts phase 3 omicron data as wait for COVID-19 vaccine approvals drags on
Fierce Biotech
Tue, 09/20/22 - 10:24 am
Clover BioPharmaceuticals
COVID-19
vaccines
boosters
clinical trials
Sandoz reports data from Phase I/III trial of denosumab for osteoporosis
Clinical Trials Arena
Tue, 09/20/22 - 10:07 am
Novartis
Sandoz
clinical trials
biosimilarts
denosumab
osteoporosis
Virios Therapeutics Announces Top-Line Results from Phase 2b Study of IMC-1 in Fibromyalgia
BioSpace
Mon, 09/19/22 - 09:17 am
Virios Therapeutics
clinical trials
herpes simplex 1
AlzeCure’s drug for Alzheimer’s shows positive effect in Phase I trial
Clinical Trials Arena
Mon, 09/19/22 - 09:11 am
AlzeCure
clinical trials
Alzheimer's disease
ACD856
FDA Review: Abiomed, Mallinckrodt, Aro and More
BioSpace
Sun, 09/18/22 - 10:42 pm
FDA
devices
Medtech
Abiomed
cardiogenic shock
clinical trials
Impella
Mallinckrodt
Kymera Therapeutics
Aro Biotherapeutics
Intellia's gene editing therapies both post early successes as evidence grows for CRISPR potential
Fierce Biotech
Fri, 09/16/22 - 10:53 am
Intellia Therapeutics
gene editing
NTLA-2001
ATTR amyloidosis
clinical trials
Regeneron
Celsion’s Phase I/II ovarian cancer trial completes subject enrolment
Clinical Trials Arena
Fri, 09/16/22 - 10:14 am
Celsion
ovarian cancer
GEN-1
clinical trials
These 3 startups are trying to improve diversity in clinical trials, a challenge experts say will take more than just tech
Stat
Thu, 09/15/22 - 10:39 am
clinical trials
clinical trial diversity
Acclinate
Trial Library
Power
Looming Amylyx drug approval decision renews debate over ALS endpoints
Clinical Trials Arena
Thu, 09/15/22 - 10:35 am
Amylyx Pharmaceuticals
AMX-0035
ALS
clinical trials
Striving for 2023 launch, Pfizer touts topline PhIII win for another mass market vaccine
Endpoints
Thu, 09/15/22 - 10:31 am
Pfizer
vaccine
meningococcal disease
clinical trials
MenABCWY
The cluster effect: Connectivity and collaboration in life sciences hubs
Clinical Trials Arena
Thu, 09/15/22 - 10:16 am
clinical trials
Human Genome Project
biotech hubs
Altimmune sees phase 1 success in tricky NASH indication with GLP-1 agonist
Fierce Biotech
Wed, 09/14/22 - 08:06 pm
Altimmune
NASH
clinical trials
pemvidutide
Pages
« first
‹ previous
…
70
71
72
73
74
75
76
77
78
…
next ›
last »